Core Insights - AngelEye Health has successfully closed a $9 million Series C funding round aimed at enhancing its neonatal and pediatric care solutions and accelerating the adoption of its AIVision platform [1][4] - The funding will support product innovation, commercial expansion, and the development of intelligent inpatient environments to improve care delivery [1] Funding Details - The equity round was led by Mountain Group Partners, with participation from Brad Whitmore and other existing investors [2] - Nationwide Children's Hospital joined as a new investor, with its finance and treasury vice-president Luke Brown set to join AngelEye's board of directors as an observer [2] Platform Usage and Impact - AngelEye Health's platform is currently utilized by over 350 hospitals, reaching approximately 20% of neonatal intensive care unit (NICU) families across the United States [2] - The platform offers real-time family connection through secure livestream video, workflow management with MilkTracker, and discharge readiness support via NICU2Home [3] Strategic Goals - The funding will enable the company to bring the AIVision platform to market while continuing to scale existing solutions that have established it as a trusted partner to numerous hospitals nationwide [4] - The introduction of AIVision in April 2025 will integrate computer vision and AI into NICU and pediatric unit settings [4]